CORRECTION -- Gritstone Reports First Quarter 2022
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
Source: globenewswire.com
Stay updated with breaking news from Specific Neoantigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
(2022-05-05 | NDAQ:GRTS) Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update